Article

dailyherald.com on 2019-06-25 19:24

AbbVie heads to record rout as Allergan deal fails to end doubts

AbbVie Inc. agreed to pay $63 billion for rival drugmaker Allergan, the latest merger in an industry where some of the biggest companies have been ...

Related news

BAbbVie Shareholders Can't Vote on Allergan Acquisition barrons.com
Wall Street
AbbVie strikes $63 billion deal for Botox-maker Allergan dailyherald.com
Dublin , New Jersey , Japan
AbbVie makes $63B bid for Botox maker Allergan Merced Sun-Star
Illinois , North Chicago , Ireland , Dublin , Merced
HAbbVie Makes $63B Bid for Botox Maker Allergan hamodia.com
Illinois , North Chicago , Ireland , Dublin , United States
BAbbVie Beats Earnings Estimates as Allergan Acquisition Nears barrons.com
Wall Street
MAbbVie closes acquisition of Allergan marketwatch.com
San Francisco , New York
Allergan may turn sights to Amgen or AbbVie The Salt Lake Tribune
New Jersey , Parsippany , Dublin , Switzerland , New York
AbbVie acquisition brings some Allergan profits back to U.S.dailyherald.com
Texas , New York , United States , New Jersey , Ireland
AbbVie Strikes Deal to Acquire Allergan for About $63 Billion wsj.com
Wall Street
BAbbVie Is Buying Allergan and Wall Street Is Doubtful barrons.com
Europe , Wall Street